The two-day scientific program of the World Conference on Oncology and Cancer Genomics 2026 is meticulously designed to provide a comprehensive and immersive experience, featuring diverse session formats to maximize learning, interaction, and knowledge exchange.
Program Structure: A Comprehensive Exploration
The variety of session formats indicates a well-rounded conference experience, catering to different learning styles and engagement preferences, typical of major international scientific meetings.
- Plenary Sessions: These high-level presentations will feature keynote and invited speakers addressing overarching themes and major breakthroughs in oncology and cancer genomics. Plenary sessions are designed to provide broad perspectives and set the intellectual agenda for the conference.
- Symposia: Focused sessions will delve into specific, rapidly advancing areas within the field. These often feature multiple expert presentations and in-depth discussions, allowing for a concentrated exploration of key topics.
- Proffered Paper Sessions: These sessions will feature oral presentations of top-scoring submitted abstracts, providing a platform for in-depth discussion of novel research findings from the broader scientific community.
- Poster Presentations: Interactive poster sessions will showcase a broad range of research, offering valuable opportunities for direct engagement with authors, informal discussions, and detailed exploration of data.
- Workshops: Practical, hands-on sessions will focus on specific techniques, methodologies, or clinical applications, providing attendees with opportunities to develop new skills or refine existing ones.
- Industry Sessions/Exhibition: Dedicated sessions and an exhibition area will showcase the latest technologies, products, and services from leading biotech and pharmaceutical companies, fostering collaboration between academia and industry.
Daily Schedule Highlights (Tentative, subject to change)
The two-day program is structured thematically to provide a logical flow and narrative for attendees, enhancing their learning experience. This thematic progression, from foundational genomic discoveries to their therapeutic and clinical implications, is a characteristic of successful scientific conferences, such as ESMO TAT’s focus on the evolution and future of drug development.
| Time Slot | Day 1: Thursday, April 02, 2026 (Genomic Foundations and Diagnostic Frontiers) | Day 2: Friday, April 03, 2026 (Therapeutic Innovations and Clinical Translation) |
| 08:00 – 09:00 | Opening Ceremony & Keynote Lecture 1: “Revolutionizing Cancer Treatment: The Transformative Odyssey of Tumor-Agnostic Drug Development in Precision Medicine” | Keynote Lecture 2: “Bridging Cancer Genomics and Drug Development: An Academic Perspective” |
| 09:00 – 10:30 | Plenary Session: “Biology Behind Circulating Tumor Cells & Plasma Biomarkers” | Plenary Session: “Early Detection of Primary Cancer, MRD Monitoring, and Tumor Evolution” |
| 10:30 – 11:00 | Coffee Break & Exhibition Visit | Coffee Break & Exhibition Visit |
| 11:00 – 12:30 | Concurrent Symposia & Proffered Paper Sessions (Cancer Genomics, Bioinformatics, Liquid Biopsy Technologies) | Concurrent Symposia & Proffered Paper Sessions (Immunotherapy, Drug Resistance, AI in Oncology) |
| 12:30 – 13:30 | Lunch Break | Lunch Break |
| 13:30 – 15:00 | Concurrent Symposia & Proffered Paper Sessions (Advanced Diagnostics, Genomic Profiling, Computational Models) | Concurrent Symposia & Proffered Paper Sessions (Targeted Therapies, Combination Strategies, Clinical Trials) |
| 15:00 – 15:30 | Refreshments Break | Refreshments Break |
| 15:30 – 17:00 | Poster Session & Networking Reception | Poster Session & Networking Reception |
| 17:00 – 17:30 | Closing Remarks & Awards Ceremony |
Export to Sheets
Thematic Tracks: Deep Dives into Specialized Areas
The scientific program will feature parallel sessions organized into thematic tracks, allowing attendees to customize their experience and delve into areas most relevant to their specific interests. This highly detailed approach, populated with specific research examples from the EACR 2022 abstracts , demonstrates the depth and specificity of the scientific content. This level of detail is crucial for attracting specialized researchers who want to see their niche represented and implicitly highlights the interdisciplinary nature of modern cancer research.
- Track 1: Advanced Cancer Genomics & Diagnostics
- Focus: This track will cover high-throughput sequencing technologies, single-cell genomics, epigenomics, genomic instability, and molecular profiling for cancer diagnosis and prognosis.
- Track 2: Liquid Biopsy: Clinical Utility & Emerging Technologies
- Focus: This track will delve into the latest in ctDNA, CTCs, exosomes, non-coding RNAs, multi-cancer early detection (MCED), minimal residual disease (MRD) monitoring, and the mechanisms of resistance detectable via liquid biopsy.
- Track 3: Precision Therapeutics & Drug Development
- Focus: This track will explore novel drug targets, small molecule inhibitors, biologics, antibody-drug conjugates (ADCs), radiotheranostics, and innovative designs for early-phase clinical trials.
- Track 4: Cancer Immunogenomics & Immunotherapy
- Focus: This track will cover the genomic determinants of immune response, neoantigens, the immune microenvironment, mechanisms of resistance to immunotherapy, and advancements in cellular and gene-based therapies.
- Track 5: Computational Oncology & AI Applications
- Focus: This track will feature research on machine learning for cancer classification, predictive modeling, network biology, in silico screening, digital pathology, and multi-modal data integration.
